The Technical Analyst
Select Language :
Alaunos Therapeutics, [TCRT]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Alaunos Therapeutics, Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Alaunos Therapeutics, is listed at the  Exchange

-2.69% $1.810

America/New_York / 28 mar 2024 @ 16:00


Alaunos Therapeutics,: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 29.04 mill
EPS: -2.25
P/E: -0.800
Earnings Date: Mar 27, 2024
SharesOutstanding: 16.04 mill
Avg Daily Volume: 0.237 mill
RATING 2024-03-28
C+
Sell
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Neutral
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/a
Gr.Profitn/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.800 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.14x
Company: PE -0.800 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$-0.122
(-106.73%) $-1.932
Date: 2024-03-28
Expected Trading Range (DAY)

$ 1.551 - 2.11

( +/- 15.25%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-22 Groenewald Ferdinand Buy 0
2024-01-20 Hogue Dale Curtis Jr. Buy 600 000 Employee Stock Option (right to buy)
2023-12-29 Hogue Dale Curtis Jr. Buy 150 000 Employee Stock Option (right to buy)
2023-12-29 Hogue Dale Curtis Jr. Buy 41 667 Employee Stock Option (right to buy)
2023-12-29 Hogue Dale Curtis Jr. Buy 0
INSIDER POWER
96.29
Last 87 transactions
Buy: 16 191 500 | Sell: 2 243 866

Forecast: 16:00 - $1.830

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $1.830
Forecast 2: 16:00 - $1.830
Forecast 3: 16:00 - $1.830
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $1.810 (-2.69% )
Volume 0.0702 mill
Avg. Vol. 0.237 mill
% of Avg. Vol 29.66 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Alaunos Therapeutics, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Alaunos Therapeutics, Inc.

RSI

Intraday RSI14 chart for Alaunos Therapeutics, Inc.

Last 10 Buy & Sell Signals For TCRT

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:32sell$2.37N/AActive
Profile picture for
            Alaunos Therapeutics, Inc.

TCRT

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers; hunTR, a human neoantigen T-cell receptor platform; and mbIL-15 to treat solid tumors. Alaunos Therapeutics, Inc. has a license agreement with PGEN Therapeutics, Inc.; research and development agreement with The University of Texas MD Anderson Cancer Center; and a patent license agreement, and research and development agreement with the National Cancer Institute. The company was formerly known as ZIOPHARM Oncology, Inc. and changed its name to Alaunos Therapeutics, Inc. in January 2022. Alaunos Therapeutics, Inc. is headquartered in Houston, Texas.

Last 10 Buy Signals

Date Signal @
YFIIUSDMar 28 - 20:53$614.57
SCNSOLUSDMar 28 - 20:54222.33
BALUSDMar 28 - 20:54$5.14
BADGERUSDMar 28 - 20:527.25
GNOUSDMar 28 - 20:51$363.96
YGGUSDMar 28 - 20:49$1.182
SWETHUSDMar 28 - 20:443 709.37
GRPUSDMar 28 - 20:4417.20
PSGUSDMar 28 - 20:445.30
HAPIUSDMar 28 - 20:4423.40

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.